Lion TCR's Series A Round

Lion TCR raised a round of funding on May 29, 2018.

Lion TCR is a clinical-stage biotechnology company, focused on the development of T cell receptor (TCR)-T cell therapy against life-threatening viral infections and viral-related cancers pertinent in …

Articles about Lion TCR's Series A Round: